Publication: 261

Publication: 261

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Clin Oncol vol 28 (22) 3617-3622

Year:: 2010
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: 333 627
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10 CA047577, U10 CA032291, CA33601, CA 32291, CA47577, CA41287, U10 CA021115, U10 CA031946, CA77651, U10 CA033601, U10 CA017145, U10 CA045418, U10 CA077440, CA77440, CA17145, U10 CA041287, U10 CA047559, U10 CA077651, CA47559, CA45418, CA21115, CA31946

Corr. Author:
Authors:: Hedy Lee Kindler Donna Niedzwiecki Donna Hollis Susan Sutherland Deborah Schrag Herbert Hurwitz Federico Innocenti Mary Frances Mulcahy Eileen O'Reilly Timothy F. Wozniak Joel Picus Pankaj Bhargava Robert J. Mayer Richard L. Schilsky Richard M. Goldberg

Networks:

Study: CALGB-80303
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Gic26, Original Reports, Gastrointestinal Cancer